查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2154600

超音波微氣泡造影劑市場：全球市場預測，2026-2032年

Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，超音波微氣泡造影劑市場規模將達到 22.8 億美元，複合年成長率為 9.30%。

主要市場統計數據
基準年 2025 12.2億美元
預計年份：2026年 13.4億美元
預測年份 2032 22.8億美元
複合年成長率 (%) 9.30%

超音波微氣泡造影劑：概述

超音波微氣泡劑透過產生強烈的聲學響應來增強超音波影像的清晰度，從而提高血流、灌注和特定病變的檢測和表徵能力。其臨床意義在於超音波的便攜性、即時成像、無電離輻射，以及在腹部、心血管、血管和腫瘤相關評估中的廣泛應用。其應用取決於已證實的臨床效用、監管部門的批准、操作人員的專業水平、保險報銷條件以及可靠的成像設備和訓練有素人員的獲取途徑。

將對比超音波應用於臨床實踐正在改變我們使用超音波的方式。

目前，對比劑的使用情況正從主要用於特殊檢查轉向更廣泛地融入診斷流程，以彌補傳統超音波和其他成像方法的不確定性。對標準化方案、影像品質、安全監測和觀察應用的進一步變革。

人工智慧正在提升微氣泡增強成像的價值。

人工智慧透過自動影像品質評估、病灶檢測、運動校正、灌注定量和決策支持，提升了微氣泡增強超音波的累積療效。雖然這些工具可以幫助臨床醫生解讀動態對比劑變化並減少操作者差異，但它們的效用取決於代表性的訓練數據、透明的檢驗、互通性以及防止自動化偏差的安全措施。因此，在產生證據時，應評估人工智慧驅動的工作流程是否具有臨床意義，而不僅依賴技術性能指標。

區域趨勢反映了醫療資源取得的差異和不同的臨床優先事項。

北美地區擁有成熟先進的影像基礎設施，專家普遍採用，並充分考慮保險報銷和證據要求。歐洲則兼具成熟的醫院體系，高度重視安全、跨境監管和標準化臨床實務。亞太地區情況差異顯著，日本、韓國和澳洲等國的先進技術應用正在穩步推進，而其他市場則存在能力建構的需求。拉丁美洲受到設備取得、專家培訓和公共資金分配不均的影響。中東地區正透過醫院現代化建設發展先進的診斷能力，而非洲則持續面臨基礎設施、人力資源、採購和維護方面的限制。在所有地區，當地的臨床指南、法律規範和供應可靠性都對技術的採用產生重大影響。

經濟和政治團體對採購、標準和准入產生影響。

東協市場在監管成熟度、醫療融資和專家資源方面存在顯著差異，因此區域協調和培訓尤其重要。金磚國家成員國的醫療體系和製造能力高度多樣化，公共採購、國內生產和都市區差距影響醫療服務的可近性。歐盟受益於協調一致的法律規範，同時在報銷制度和臨床應用方面仍存在國家差異。七國集團（G7）國家普遍擁有先進的診斷影像生態系統，但在實證醫學、成本效益和人力資源方面面臨挑戰。海灣合作理事會（GCC）國家正在投資建設先進的醫院設施和集中採購，而北約成員國的醫療體係成熟度差異很大，且往往優先考慮診斷服務的韌性、互通性和連續性。

各國具體優先事項涵蓋創新領導力到能力建構等領域。

澳洲強調實證診斷影像、農村地區的醫療服務可近性以及醫療專業人員的部署。巴西和墨西哥面臨雙重挑戰：既要推廣先進的診斷技術，又要解決區域不平等和公共部門資源限制問題。加拿大和美國擁有先進的診斷影像能力，其應用受到臨床證據、保險報銷、認證以及專家資源等因素的影響。中國正在加強國內醫療能力和技術發展，而印度則在快速都市化中努力平衡大都會圈以外地區醫療服務可近性嚴重不均的問題。日本和韓國在超音波診斷方面展現出先進的專業技術，並在技術應用方面取得了顯著進展。法國、德國、義大利、西班牙和英國的特點是擁有完善的醫療體系、良好的監管合規性、嚴格的預算管理以及多樣化的保險報銷機制。俄羅斯的營商環境受到醫療現代化、醫療物資供應的連續性以及專業技術可近性的影響。

領導者的優先事項：證明效用、建立能力和確保取得途徑。

產業領導者應優先考慮能夠證明微氣泡增強超音波如何革新診斷、治療方案製定、後續觀察和轉診決策的證據。他們還應制定培訓計劃，涵蓋患者選擇、操作流程、影像檢查、觀察解讀以及不利事件應對措施，並根據當地臨床實際情況進行調整。與醫院和專業協會建立合作關係有助於規範流程並進行實際檢驗。各機構也應增強供應韌性，提供可互通的工作流程工具，並透過透明的管治評估人工智慧能力。市場准入計畫應考慮監管文件、報銷理由、採購要求以及在都市區和醫療資源匱乏地區的公平部署。

調查方法：基於證據的臨床和營運狀況評估。

本執行摘要採用結構化的定性評估方法，對超音波微氣泡劑進行分析，涵蓋臨床應用、技術發展、醫療基礎設施、法規、報銷、人力資源、採購和區域市場准入等面向。分析結果按已識別的地區、經濟和政治集團以及國家進行分類，並區分了既有用途和新興機會。本摘要不包含市場估算和預測、市場佔有率、預測、公司特定聲明以及未經證實的性能聲明。隨著臨床指南、監管決策、報銷政策、安全性證據和人工智慧檢驗研究的不斷發展，本摘要的解讀也應隨之更新。

結論：永續應用取決於已證實的臨床價值。

超音波微氣泡造影劑在先進超音波技術、微創診斷和日益數據驅動的臨床護理的交匯點佔據著至關重要的地位。其持續應用更取決於可靠的證據、熟練的操作人員、整合的工作流程、負責任的人工智慧以及設備和專業知識的公平獲取，而非技術本身的創新性。那些將產品開發與臨床結果、教育、監管合規和完善的交付系統相結合的領導者，將更有能力支持其在各種醫療保健系統中的永續應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：超音波微氣泡造影劑市場：依產品類型分類

  • 多泡體
  • 單氣泡
  • 標靶造影劑

第8章：超音波微氣泡造影劑市場：依應用分類

  • 心血管系統
  • 胃腸病學
  • 腫瘤學
    • 乳癌
    • 肝癌
    • 肺癌
  • 泌尿系統

第9章：超音波微氣泡造影劑市場：依最終用戶分類

  • 診所
  • 診斷中心
  • 醫院
    • 二級醫療保健
    • 三級醫療保健

第10章：超音波微氣泡造影劑市場：依分銷管道分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章：超音波微氣泡造影劑市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：超音波微氣泡造影劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：超音波微氣泡造影劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Advanced Microbubbles Inc.
  • Aspect Imaging Ltd.
  • BCM Technologies, Inc.
  • Biocell Technology LLC
  • Bracco Suisse SA
  • Canon Medical Systems Corporation
  • CURASIS GmbH
  • Daiichi Sankyo Company, Limited
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare AS
  • Hitachi, Ltd.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt plc
  • Microbubble Therapeutics Pty Ltd
  • Mindray Medical International Limited
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG
  • Targeson, Inc.

第16章 主要專家

Product Code: MRR-537DB9F46E58

The Ultrasonic Microbubble Contrast Agents Market is projected to grow by USD 2.28 billion at a CAGR of 9.30% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.34 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 9.30%

Ultrasonic Microbubble Contrast Agents: Executive Overview

Ultrasonic microbubble contrast agents enhance ultrasound visualization by producing strong acoustic responses that improve the detection and characterization of blood flow, perfusion, and selected lesions. Their clinical relevance is tied to ultrasound's portability, real-time imaging, absence of ionizing radiation, and expanding use in abdominal, cardiovascular, vascular, and oncology-related assessment. Adoption depends on validated clinical utility, regulatory authorization, operator expertise, reimbursement conditions, and reliable access to imaging equipment and trained personnel.

Clinical Integration Is Reshaping Contrast-Enhanced Ultrasound

The landscape is shifting from contrast agents being used primarily for specialized examinations toward broader integration into diagnostic workflows where conventional ultrasound or other imaging methods leave uncertainty. Greater emphasis on standardized protocols, image quality, safety monitoring, and reproducible interpretation is supporting more consistent clinical use. Additional change is coming from point-of-care imaging, improved transducer technology, workflow digitization, and efforts to reduce avoidable referrals or repeat examinations while preserving diagnostic confidence.

Artificial Intelligence Is Increasing the Value of Microbubble-Enhanced Imaging

Artificial intelligence is contributing to the cumulative impact of microbubble-enhanced ultrasound through automated image quality assessment, lesion detection, motion correction, perfusion quantification, and decision support. These tools can help clinicians interpret dynamic contrast behavior and reduce variability between operators, but their usefulness depends on representative training data, transparent validation, interoperability, and safeguards against automation bias. Evidence generation should therefore assess AI-enabled workflows against clinically meaningful outcomes rather than relying solely on technical performance metrics.

Regional Dynamics Reflect Uneven Access and Different Clinical Priorities

North America is characterized by established advanced-imaging infrastructure, specialist adoption, and attention to reimbursement and evidence requirements. Europe combines mature hospital systems with strong emphasis on safety, cross-border regulation, and standardized clinical practice. Asia-Pacific presents substantial diversity, with advanced adoption in countries such as Japan, South Korea, and Australia alongside capacity-building needs in other markets. Latin America is influenced by uneven access to equipment, specialist training, and public-sector funding. The Middle East is developing advanced diagnostic capacity through hospital modernization, while Africa continues to face constraints involving infrastructure, workforce availability, procurement, and maintenance. Across all regions, local clinical guidelines, regulatory pathways, and supply reliability materially affect implementation.

Economic and Political Groups Shape Procurement, Standards, and Access

ASEAN markets differ considerably in regulatory maturity, healthcare financing, and specialist availability, making regional harmonization and training particularly relevant. BRICS members span highly varied health systems and manufacturing capabilities, with access shaped by public procurement, domestic production, and urban-rural disparities. The European Union benefits from coordinated regulatory structures while retaining national differences in reimbursement and clinical adoption. G7 countries generally have advanced imaging ecosystems but face evidence, cost-effectiveness, and workforce pressures. GCC countries are investing in sophisticated hospital capacity and centralized procurement, whereas NATO members reflect a broad range of health-system maturity and may emphasize resilience, interoperability, and continuity of diagnostic services.

Country-Level Priorities Range from Innovation Leadership to Capacity Building

Australia emphasizes evidence-based imaging, rural access, and workforce distribution. Brazil and Mexico face the dual challenge of expanding advanced diagnostics while addressing regional inequality and public-sector resource constraints. Canada and the United States have sophisticated imaging capabilities, with adoption influenced by clinical evidence, reimbursement, accreditation, and specialist availability. China is strengthening domestic healthcare capacity and technology development, while India is balancing rapid urban growth with major access gaps outside metropolitan centers. Japan and South Korea have advanced ultrasound expertise and strong technology adoption. France, Germany, Italy, Spain, and the United Kingdom are shaped by established healthcare systems, regulatory compliance, budget discipline, and differing reimbursement pathways. Russia's operating environment is influenced by healthcare modernization, supply continuity, and access to specialized technology.

Priorities for Leaders: Prove Utility, Build Capability, and Secure Access

Industry leaders should prioritize evidence that demonstrates how microbubble-enhanced ultrasound changes diagnosis, treatment planning, monitoring, or referral decisions. They should develop training programs covering patient selection, administration, image acquisition, interpretation, and adverse-event readiness, with content adapted to local practice. Partnerships with hospitals and professional societies can support protocol standardization and real-world validation. Organizations should also strengthen supply resilience, provide interoperable workflow tools, and evaluate AI features through transparent governance. Market access planning should address regulatory documentation, reimbursement evidence, procurement requirements, and equitable deployment across urban and underserved settings.

Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses a structured qualitative assessment of ultrasonic microbubble contrast agents across clinical adoption, technology development, healthcare infrastructure, regulation, reimbursement, workforce, procurement, and regional access conditions. The analysis organizes findings across the specified regions, economic and political groups, and countries, while distinguishing established applications from emerging opportunities. It excludes market estimates, market shares, forecasts, company-specific claims, and unsupported performance assertions. Interpretation should be updated as clinical guidelines, regulatory decisions, reimbursement policies, safety evidence, and AI validation studies evolve.

Conclusion: Sustainable Adoption Depends on Demonstrated Clinical Value

Ultrasonic microbubble contrast agents occupy an important position at the intersection of advanced ultrasound, minimally invasive diagnosis, and increasingly data-driven clinical care. Their continued adoption will depend less on technical novelty alone than on reliable evidence, skilled users, integrated workflows, responsible AI, and equitable access to equipment and expertise. Leaders that connect product development with clinical outcomes, education, regulatory readiness, and resilient delivery will be better positioned to support durable use across diverse healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ultrasonic Microbubble Contrast Agents Market, by Product Type

  • 7.1. Introduction
  • 7.2. Multi Bubble
  • 7.3. Single Bubble
  • 7.4. Targeted Agent

8. Ultrasonic Microbubble Contrast Agents Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Gastroenterology
  • 8.4. Oncology
    • 8.4.1. Breast Cancer
    • 8.4.2. Liver Cancer
    • 8.4.3. Lung Cancer
  • 8.5. Urology

9. Ultrasonic Microbubble Contrast Agents Market, by End User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals
    • 9.4.1. Secondary Care
    • 9.4.2. Tertiary Care

10. Ultrasonic Microbubble Contrast Agents Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy

11. Ultrasonic Microbubble Contrast Agents Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Ultrasonic Microbubble Contrast Agents Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Ultrasonic Microbubble Contrast Agents Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Advanced Microbubbles Inc.
  • 15.2. Aspect Imaging Ltd.
  • 15.3. BCM Technologies, Inc.
  • 15.4. Biocell Technology LLC
  • 15.5. Bracco Suisse SA
  • 15.6. Canon Medical Systems Corporation
  • 15.7. CURASIS GmbH
  • 15.8. Daiichi Sankyo Company, Limited
  • 15.9. Esaote SpA
  • 15.10. Fujifilm Holdings Corporation
  • 15.11. GE Healthcare AS
  • 15.12. Hitachi, Ltd.
  • 15.13. Lantheus Medical Imaging, Inc.
  • 15.14. Mallinckrodt plc
  • 15.15. Microbubble Therapeutics Pty Ltd
  • 15.16. Mindray Medical International Limited
  • 15.17. Samsung Medison Co., Ltd.
  • 15.18. Siemens Healthineers AG
  • 15.19. Targeson, Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Ultrasonic Microbubble Contrast Agents Market, Years Considered for the Study
  • FIGURE 2. Global Ultrasonic Microbubble Contrast Agents Market, Research Design
  • FIGURE 3. Global Ultrasonic Microbubble Contrast Agents Market, Research Framework
  • FIGURE 4. Global Ultrasonic Microbubble Contrast Agents Market, Data Triangulation
  • FIGURE 5. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 9. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 11. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Ultrasonic Microbubble Contrast Agents Market Segmentation & Coverage
  • TABLE 2. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Multi Bubble Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Multi Bubble Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Multi Bubble Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Single Bubble Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Single Bubble Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Single Bubble Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Targeted Agent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Targeted Agent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Targeted Agent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 14. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Urology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Urology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Urology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 36. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Secondary Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Secondary Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Secondary Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Tertiary Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Tertiary Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Tertiary Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 52. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 69. North America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 71. North America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 72. North America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 73. North America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 74. North America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 75. North America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 78. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 79. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 80. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 81. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 82. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 83. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 85. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 86. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 87. Europe Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 88. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 89. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 90. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 92. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 93. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 94. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 95. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 96. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 97. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 99. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 100. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 101. Africa Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 102. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 103. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 104. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 112. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 114. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 115. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 116. GCC Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 118. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 119. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 121. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 122. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 123. European Union Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 125. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 126. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 128. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 129. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 130. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 132. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 135. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 136. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 137. G7 Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 139. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 140. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 142. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 143. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 144. NATO Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 146. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 147. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 148. United States Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 149. United States Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 150. United States Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 151. United States Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 152. United States Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 153. United States Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 154. United States Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 155. Canada Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 156. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 157. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 158. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 159. Canada Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 161. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 162. Mexico Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 163. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 164. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 165. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 166. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 167. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 168. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 169. Brazil Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 170. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 171. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 172. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 173. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 175. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 176. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 177. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 178. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 179. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 180. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 182. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Germany Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 184. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 185. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 186. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 187. Germany Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 188. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 189. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. France Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 191. France Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 192. France Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 193. France Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 194. France Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 195. France Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 196. France Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. Russia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 198. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 199. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 201. Russia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 203. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 204. Italy Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 205. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 206. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 207. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 208. Italy Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 210. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 211. Spain Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 212. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 213. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 214. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 215. Spain Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 217. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 218. China Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 219. China Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 220. China Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 221. China Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 222. China Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 223. China Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 224. China Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. India Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 226. India Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 227. India Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 228. India Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 229. India Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 230. India Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 231. India Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 232. Japan Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 233. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 234. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 235. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 236. Japan Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 238. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. Australia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 240. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 241. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 242. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 243. Australia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 244. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 245. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. South Korea Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 247. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 248. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 250. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 251. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 252. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 253. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025
  • TABLE 254. Global Ultrasonic Microbubble Contrast Agents Market, Key Experts